Related Experiment Video
Updated: Jul 3, 2026
Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model
Abstract:
Muscular dystrophies make up a group of genetic neuromuscular disorders that involve severe muscle wasting. TGF-β-activated kinase 1 (TAK1) is an important signaling protein that regulates cell survival, growth, and inflammation. TAK1 has been recently found to promote myofiber growth in the skeletal muscle of adult mice. However, the role of TAK1 in muscle diseases remains poorly understood. In the present study, we have investigated how TAK1 affects the progression of dystrophic phenotype in the mdx mouse model of Duchenne muscular dystrophy (DMD). TAK1 is highly activated in the dystrophic muscle of mdx mice during the peak necrotic phase. While targeted inducible inactivation of TAK1 inhibits myofiber injury in young mdx mice, it results in reduced muscle mass and contractile function. TAK1 inactivation also causes loss of muscle mass in adult mdx mice. By contrast, forced activation of TAK1 through overexpression of TAK1 and TAB1 induces myofiber growth without having any deleterious effect on muscle histopathology. Collectively, our results suggest that TAK1 is a positive regulator of skeletal muscle mass and that targeted regulation of TAK1 can suppress myonecrosis and ameliorate disease progression in DMD.
Insights
TGF-β-activated kinase 1 (TAK1) regulates skeletal muscle mass. In Duchenne muscular dystrophy (DMD), TAK1 activation suppresses muscle wasting and injury, suggesting it
Area of Science:
- Biochemistry
- Cell Biology
- Genetics
Background:
- Muscular dystrophies are genetic neuromuscular disorders causing severe muscle wasting.
- TGF-β-activated kinase 1 (TAK1) is a signaling protein regulating cell survival, growth, and inflammation.
- TAK1 promotes skeletal muscle myofiber growth in adult mice, but its role in muscle disease is unclear.
Purpose of the Study:
- To investigate the role of TAK1 in the progression of the dystrophic phenotype in mdx mice, a model for Duchenne muscular dystrophy (DMD).
Main Methods:
- Examined TAK1 activation levels in dystrophic muscles of mdx mice during peak necrosis.
- Assessed the effects of targeted inducible TAK1 inactivation on myofiber injury, muscle mass, and contractile function in young and adult mdx mice.
- Investigated the impact of forced TAK1 activation via overexpression of TAK1 and TAB1 on muscle histopathology and myofiber growth.
Main Results:
- TAK1 is highly activated in dystrophic muscles of mdx mice during the peak necrotic phase.
- Targeted inactivation of TAK1 inhibited myofiber injury in young mdx mice but led to reduced muscle mass and contractile function.
- TAK1 inactivation caused muscle mass loss in adult mdx mice.
- Forced activation of TAK1 induced myofiber growth without adverse effects on muscle histopathology.
Conclusions:
- TAK1 acts as a positive regulator of skeletal muscle mass.
- Targeted regulation of TAK1 can suppress myonecrosis and potentially ameliorate disease progression in Duchenne muscular dystrophy.
